These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23815567)

  • 21. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 22. Neonatal diabetes and insulin pump therapy.
    Beardsall K; Pesterfield CL; Acerini CL
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of meals with different glycaemic index on postprandial blood glucose response in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Parillo M; Annuzzi G; Rivellese AA; Bozzetto L; Alessandrini R; Riccardi G; Capaldo B
    Diabet Med; 2011 Feb; 28(2):227-9. PubMed ID: 21219435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study.
    Davidson JA; Perez A; Zhang J;
    Diabetes Obes Metab; 2006 Mar; 8(2):164-74. PubMed ID: 16448520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
    Hernar I; Haltbakk J; Broström A
    J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application and practice of intensive insulin therapy].
    Kishikawa H; Soejima H; Tamama Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D; Moberg E; Palmér M
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract]   [Full Text] [Related]  

  • 29. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 30. Case 2: Generalized Anasarca in 15-year-old Girl With Type 1 Diabetes Mellitus.
    Myers WT; Wintergerst KA; Kingery SE; Foster MB
    Pediatr Rev; 2016 Feb; 37(2):81-2. PubMed ID: 26834228
    [No Abstract]   [Full Text] [Related]  

  • 31. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges.
    Davies M
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S14-22. PubMed ID: 15306833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.
    Reichel A; Rietzsch H; Köhler HJ; Pfützner A; Gudat U; Schulze J
    Exp Clin Endocrinol Diabetes; 1998; 106(3):168-72. PubMed ID: 9710355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Continuous subcutaneous insulin infusion].
    Ito H; Kanatsuka A
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract]   [Full Text] [Related]  

  • 35. Refining basal insulin therapy: what have we learned in the age of analogues?
    Devries JH; Nattrass M; Pieber TR
    Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin neuritis and diabetic cachectic neuropathy: a review.
    Knopp M; Srikantha M; Rajabally YA
    Curr Diabetes Rev; 2013 May; 9(3):267-74. PubMed ID: 23506377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin oedema in a child with newly diagnosed diabetes mellitus.
    Aravamudhan A; Gardner C; Smith C; Senniappan S
    Eur J Pediatr; 2014 May; 173(5):685-7. PubMed ID: 23712377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral cataracts and insulin oedema in a child with type 1 diabetes mellitus.
    Goturu A; Jain N; Lewis I
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23378550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.
    Gibbons CH; Freeman R
    Brain; 2015 Jan; 138(Pt 1):43-52. PubMed ID: 25392197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.